PMC7522403_01
Computed tomography images of the lungs. (A) Computed tomography scan obtained in December 2017 showing increased size of metastatic nodules (yellow arrows) in both right and left lower lobes. (B) Computed tomography scan obtained in January 2018 showing slightly decreased size of metastatic nodules (yellow arrows) in both the right and left lower lobes. (C) Computed tomography scan obtained in July 2020 showing slightly aggravated metastatic nodules (yellow arrows) in both the right and left lower lobes.
IJGM-13-699-g0001.jpg
PMC7522403_01_IJGM-13-699-g0001.jpg
f0001
After 5 years of observation, in December 2017, he developed symptoms such as frequent cough and chest pain, caused by aggravated lung metastases (Figure 1A), for which he started receiving 24 mg of lenvatinib per day. However, it showed that thyroid cancer burden was mildly improved (Figure 1B). In June 2020, more than 2 years later, the last imaging follow-up showed relatively indolent thyroid cancer disease course (Figure 1C).
Computed tomography images of the abdomen obtained in January 2018. (A) Computed tomography image of the pancreas showing heterogeneous fluid collection and fat infiltration (yellow arrows) around the tail. (B) Computed tomography image showing splenic subcapsular fluid collection (yellow arrows). (C) Computed tomography image showing secondary colitis at the descending colon (yellow arrows).
IJGM-13-699-g0002.jpg
PMC7522403_01_IJGM-13-699-g0002.jpg
f0002
A computed tomography scan with contrast enhanced presented heterogeneous fluid collection around and fat infiltration into the tail of the pancreas, in addition to splenic subcapsular fluid collection and secondary colitis at the descending colon, without any biliary abnormalities (Figure 2).